☆ 4.7 Article

Phase 1 Dose Escalation Study of SBRT Using 3 Fractions for Locally Advanced Pancreatic Cancer

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Oncology

Cancer statistics, 2022

Rebecca L. Siegel et al.

Summary: Each year, the American Cancer Society compiles data on cancer occurrence and outcomes in the United States. The latest data shows that breast and prostate cancer progress has stagnated, while lung cancer has shown improvements in survival rates. Lung cancer incidence for advanced disease has declined while localized-stage rates have increased, resulting in higher survival rates. Mortality patterns align with incidence trends, with lung cancer deaths declining rapidly, breast cancer deaths slowing, and prostate cancer deaths stabilizing.

CA-A CANCER JOURNAL FOR CLINICIANS (2022)

添加到收藏夹

Article Oncology

Stereotactic ablative radiation for pancreatic cancer on a 1.5 Telsa magnetic resonance-linac system

Kathryn R. Tringale et al.

Summary: This study reported promising local control and overall survival outcomes with no severe toxicity in patients with locally advanced pancreatic cancer using ablative radiation therapy (A-RT) delivered with the 1.5 T MR Linac. Further long-term follow-up is needed to assess long-term outcomes.

PHYSICS & IMAGING IN RADIATION ONCOLOGY (2022)

添加到收藏夹

Article Oncology

Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer

Anand Mahadevan et al.

Summary: Using tumor control probability models, this study evaluates the effectiveness of different SBRT treatment regimens for localized pancreatic cancer. The results suggest a dose response relationship, indicating the need for additional data to better understand the dose or fractionation-response of SBRT for PCa.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2021)

添加到收藏夹

Article Oncology

A phase II study of stereotactic radiotherapy after FOLFIRINOX for locally advanced pancreatic cancer (LAPC-1 trial): Long-term outcome

M. A. Teriaca et al.

Summary: This study reported the long-term outcome of LAPC patients who underwent FOLFIRINOX followed by SBRT. Patients who received SBRT had a longer median overall survival, and those who underwent surgery had significantly better survival compared to the unresected group.

RADIOTHERAPY AND ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Association of Ablative Radiation Therapy With Survival Among Patients With Inoperable Pancreatic Cancer

Marsha Reyngold et al.

Summary: Ablative radiation therapy following multiagent induction therapy for locally advanced pancreatic cancer is associated with durable locoregional tumor control and favorable survival outcomes. Prospective randomized trials in patients with inoperable LAPC are warranted.

JAMA ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Stereotactic MR-guided online adaptive radiotherapy reirradiation (SMART reRT) for locally recurrent pancreatic adenocarcinoma: A case report

Delia G. Doty et al.

Summary: SMART reRT, featuring online adaptive radiotherapy, was used for the first time in the reirradiation setting for locally recurrent pancreatic adenocarcinoma. The patient tolerated treatment well with minimal fatigue, demonstrating the potential for improved therapeutic ratio and long-term outcomes with this approach. Future studies are needed to further assess the efficacy and safety of dose escalated MR-guided reRT.

MEDICAL DOSIMETRY (2021)

添加到收藏夹

Article Oncology

Feasibility of ablative stereotactic body radiation therapy of pancreas cancer patients on a 1.5 Tesla magnetic resonance-linac system using abdominal compression

Neelam Tyagi et al.

Summary: This study evaluated the feasibility of treating patients with locally advanced pancreatic cancer using abdominal compression, and found that dose-volume constraints for some organs-at-risk were exceeded. Longer follow-up is needed to observe the dosimetric impact of intrafraction motion on gastrointestinal toxicity.

PHYSICS & IMAGING IN RADIATION ONCOLOGY (2021)

添加到收藏夹

Article Oncology

Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer

Soumon Rudra et al.

CANCER MEDICINE (2019)

添加到收藏夹

Article Oncology

Results of a prospective phase 2 clinical trial of induction gemcitabine/capecitabine followed by stereotactic ablative radiation therapy in borderline resectable or locally advanced pancreatic adenocarcinoma

Kimmen Quan et al.

PRACTICAL RADIATION ONCOLOGY (2018)

添加到收藏夹

Article Oncology

Outcomes for patients with locally advanced pancreatic adenocarcinoma treated with stereotactic body radiation therapy versus conventionally fractionated radiation

Jim Zhong et al.

CANCER (2017)

添加到收藏夹

Article Oncology

Focal Radiation Therapy Dose Escalation Improves Overall Survival in Locally Advanced Pancreatic Cancer Patients Receiving Induction Chemotherapy and Consolidative Chemoradiation

Sunil Krishnan et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2016)

添加到收藏夹

Article Medicine, General & Internal

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib The LAP07 Randomized Clinical Trial

Pascal Hammel et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)

添加到收藏夹

Article Oncology

Phase 2 Multi-institutional Trial Evaluating Gemcitabine and Stereotactic Body Radiotherapy for Patients With Locally Advanced Unresectable Pancreatic Adenocarcinoma

Joseph M. Herman et al.

CANCER (2015)

添加到收藏夹

Article Oncology

SINGLE-FRACTION STEREOTACTIC BODY RADIATION THERAPY AND SEQUENTIAL GEMCITABINE FOR THE TREATMENT OF LOCALLY ADVANCED PANCREATIC CANCER

Devin Schellenberg et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)

添加到收藏夹

Article Oncology

Phase III trial comparing intensive induction chemoradiotherapy (60 Gy, infusional 5-FU and intermittent cisplatin) followed by maintenance gemcitabine with gemcitabine alone for locally advanced unresectable pancreatic cancer.: Definitive results of the 2000-01 FFCD/SFRO study

B. Chauffert et al.

ANNALS OF ONCOLOGY (2008)

添加到收藏夹

Article Oncology

Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer

Devin Schellenberg et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2008)

添加到收藏夹

Meeting Abstract Oncology

A randomized phase III study of gemcitabine in combination with radiation therapy versus gemcitabine alone in patients with localized, unresectable pancreatic cancer: E4201

P. J. Loehrer et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

添加到收藏夹

Article Oncology

Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer

AC Koong et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)

添加到收藏夹

Article Oncology

Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma

M Hoyer et al.

RADIOTHERAPY AND ONCOLOGY (2005)

添加到收藏夹

Article Oncology

Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer

AC Koong et al.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)

添加到收藏夹

Review Biochemistry & Molecular Biology

Radiation and ceramide-induced apoptosis

R Kolesnick et al.

ONCOGENE (2003)

添加到收藏夹

Article Multidisciplinary Sciences

Tumor response to radiotherapy regulated by endothelial cell apoptosis

M Garcia-Barros et al.

SCIENCE (2003)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.